Calyxt Stock

Calyxt Equity

Delisted

The The Equity of Calyxt (CLXT) as of Aug 7, 2026 is 7.23 M USD. In the previous year, The Equity was 14.13 M USD — a change of -48.82% (lower).

Equity

7.23 MUSD

YoY

-48.82%

Last updated:

In 2026, Calyxt's equity was 7.23 M USD, a -48.82% increase from the 14.13 M USD equity in the previous year.

Access this data via the Eulerpool API

Calyxt Stock analysis

What does Calyxt do? Calyxt Inc. is a US company specializing in the development and marketing of genetically modified plants. The company was founded in Minnesota in 2010 with the aim of producing high-quality, healthy, and environmentally friendly products that meet the requirements of modern and sustainable nutrition. History The history of Calyxt Inc. began with the idea of revolutionizing the cultivation of crops. The company was founded by Cellectis SA, which already had experience in the field of molecular biology. Calyxt developed technological processes for rapid genetic manipulation of plants that had the potential to change the entire agricultural industry. Business Model Calyxt follows an "end-to-end" business model, meaning the company offers products and services along the entire value chain. This ranges from the development of new plants through genetic modifications to the distribution and marketing of the end products. Divisions Calyxt specializes in the development of plant varieties optimized through genetic manipulation. The company has various divisions that focus on specific plant species, including: - Soybeans: Calyxt has developed a new variety of soybeans that contains a higher proportion of oleic acid, which improves the durability and quality of the beans. - Wheat: The company has also developed a variety of wheat that is low in gluten. This allows people with celiac disease or other reasons to avoid gluten to consume this variety. - Potatoes: Calyxt has developed a new variety of potatoes that contains less acrylamide than other varieties. Acrylamide is formed during the production of fries and chips and is suspected to cause cancer. Products Calyxt offers various products made from the plants they have developed, including: - Soybean oil: Calyxt soybean oil contains a higher proportion of healthy omega-3 fatty acids compared to conventional soybean oil. - Flour: Calyxt wheat flour is low in gluten and can be consumed by people with celiac disease or other reasons to avoid gluten. - Fries and chips: Calyxt potatoes contain less acrylamide than conventional potatoes, resulting in the formation of fewer harmful substances during the preparation of fries and chips. Conclusion Calyxt Inc. is an American company that develops genetically modified plants and connects them with customers, mainly in the food sector. The company aims to produce healthy, environmentally friendly, and high-quality products that meet the requirements of modern and sustainable nutrition. Various plant species are genetically modified to improve the durability and quality of the products while minimizing health risks. Calyxt Inc. offers various products made from the plants they have developed, with a focus on the production of fries and chips, as well as the distribution of soybean oil and low-gluten wheat flour. Calyxt has the potential to change modern agriculture through its innovative and sustainable products. Calyxt is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Calyxt's Equity

Calyxt's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Calyxt's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Calyxt's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Calyxt's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Calyxt’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Calyxt stock

The Equity of Calyxt is 7.23 M USD in 2026.

The Equity of Calyxt changed from 14.13 M USD to 7.23 M USD, representing a -48.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Calyxt since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Calyxt historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Calyxt

All Key Metrics — Calyxt